Notice of Compliance Information
From Health Canada
- Notice of Compliance date :
- 2026-04-30
- Manufacturer :
- ELI LILLY CANADA INC
- Product type:
- Biologic
- NOC with conditions:
- No
- Submission type:
- New Drug Submission (NDS)
- Submission class:
- New Active Substance (NAS)
Brand 1 of 1 :
KISUNLA
Product 1 of 1 :
Drug identification number:
02567725
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
| Ingredient | Strength |
|---|---|
| DONANEMAB | 17.5 MG/ML |